The piece weighs Wegovy pill sales of over 5 million US prescriptions against Viking's VK2735, where monthly maintenance dosing kept 85% of weight loss.
Recap by typeshit. Full story at TradingView.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
A short clip from an optometrist on reports linking GLP-1 medications to vision loss. Little detail beyond the topic itself.
Loading…